FOX04 DRIpeptidedosage The FOXO4-DRI peptide is emerging as a significant compound in the field of aging research, primarily recognized for its role as a senolytic agent. This specialized peptide targets senescent cells, often referred to as "zombie cells," which accumulate in the body with age and contribute to various age-related diseases and tissue dysfunctionOne minor point: At a few places you change the spelling of FOXO4 to FOX04 (FOX ... peptide,achieves organ (and hair) recovery in old mice.. By selectively inducing apoptosis (programmed cell death) in these senescent cells, FOXO4-DRI holds promise for rejuvenating tissues, restoring hormonal balance, and potentially mitigating some aspects of the aging process. Its mechanism involves blocking the interaction between FOXO4 and p53, a critical pathway for maintaining cellular health and preventing mutations.
Senescent cells are cells that have stopped dividing but resist dying. While this process can initially prevent cancer, their prolonged presence leads to the secretion of pro-inflammatory molecules (the senescence-associated secretory phenotype, or SASP), which can damage surrounding tissues and promote aging. FOXO4-DRI, a cell-permeable peptide antagonist, is designed to disrupt the FOXO4-p53 interaction.FOXO4-DRI | FOXO4/p53 Interaction Blocker In senescent cells, FOXO4 often accumulates abnormally. By interfering with this protein complex, FOXO4-DRI can trigger the removal of these dysfunctional cells, thereby improving the cellular microenvironment. Research has demonstrated that FOXO4-DRI can selectively remove senescent cells, leading to improved tissue function and regeneration in animal modelsTargeted Apoptosis of Senescent Cells Restores Tissue ....
The primary mechanism of action for FOXO4-DRI is its ability to induce apoptosis in senescent cells.FOXO4-DRI is a synthetic D-retro-inverso peptidedesigned to target cellular senescence, a key driver of aging and age-related disease. This is achieved by blocking the interaction between the Forkhead box protein O4 (FOXO4) and p53Buy FOXO4-DRI 10mg (Proxofim) | 99% Purity (USA Made). P53 is a crucial tumor suppressor protein that plays a vital role in cell cycle arrest and apoptosis when DNA damage is detected作者：Y Huang·2021·被引用次数：51—FOXO4-DRI is able to remove the senescent cells in PDL9 chondrocytes, but its utility in promoting cartilage formation from the in vitro expanded chondrocytes .... In senescent cells, this interaction can contribute to their survival.Peptide Therapy for Anti-Aging: How It Works and What to Expect FOXO4-DRI perturbs this interaction, leading to the selective death of senescent cells.
The potential benefits observed in studies, primarily in animal models, include:
* Tissue Regeneration: By clearing senescent cells, FOXO4-DRI has shown potential in restoring tissue function and promoting regeneration.
* Hormonal Balance: Studies, particularly those involving naturally aged mice, suggest that FOXO4-DRI can alleviate age-related testosterone secretion insufficiency by improving the testicular microenvironment.
* Organ and Hair Recovery: In certain animal studies, the peptide has been noted for achieving organ and hair recovery in aged subjects.FOXO4-DRI is a cell-permeable peptide antagonistthat blocks the interaction of FOXO4 and p53. Products are for research use only. Not for human use.
* Enhanced Cellular Potential: Research indicates that FOXO4-DRI treatment can remove senescent cells from expanded chondrocytes, potentially enhancing their regenerative capabilities.
FOXO4-DRI is currently a research peptide, meaning its applications are primarily within scientific exploration and laboratory settings. It is often described as a specialized research peptide developed for advanced scientific exploration in cell biology, aging, and related fields. While promising results have been observed in preclinical studies, it is crucial to note that FOXO4-DRI is not yet approved for human therapeutic use. Products available for purchase are typically intended for research purposes only.
The peptide is often synthesized with high purity (e.g.FOXO4-DRI peptideis selective in nature and exerts this potential action only on cells that have become dysfunctional over time due to aging, known as ..., >99%) and is characterized by its appearance as a white powder. Variations such as the "Retro-Inverso" form are also developed, which can potentially enhance the peptide's stability and half-lifeFOXO4-DRI is a cell-permeable peptide antagonist.FOXO4-DRI is an anti-aging peptide that induces apoptosis in senescent cells.. The CAS number for FOXO4-DRI is commonly listed as 2460055-10-9.
As a senolytic agent, FOXO4-DRI represents a promising avenue for combating age-related decline. Its ability to target and eliminate senescent cells offers a novel approach to age-related interventions. However, research is ongoing to fully understand its long-term effects, optimal dosage protocols, and potential side effects in more complex biological systems. The development of FOXO4-DRI highlights the growing interest in peptide therapeutics for their targeted action and potential for high efficacy. While the clinical application of FOXO4-DRI is still in its early stages, its scientific basis and demonstrated effects in preclinical models suggest a significant role in future anti-aging and regenerative medicine strategies.
Join the newsletter to receive news, updates, new products and freebies in your inbox.